 |
|
|
 |
|
Rationale:
- Although most conjunctivitis can be diagnosed on history and physical examination as infectious, the nature of the infectious
agent, a virus or bacteria, is often difficult to determine. In-office testing for adenovirus may assist in establishing a
correct diagnosis, but in some unusual cases and in patients unresponsive to treatment, special tests may be indicated.
|
|
Evidence:
- Consensus and recommendations of 19.
- Various diagnostic tests are evaluated in a cohort of 150 patients with presumed chlamydial conjunctivitis (20).
- Laboratory review was done that included current diagnostic methods for chlamydia trachomatis (21).
- A retrospective review of immunofluorescence and immunoperoxidase staining in 166 pathology specimens considered the role
of these techniques in examining conjunctivitis biopsy results in patients with ocular cicatricial pemphigoid (22).
- A review examined the effectiveness of immunofluorescence, immunoperoxidase, immune adherence hemagglutination, radioimmunoassay,
enzyme-linked immunosorbent assay, and immunoelectron microscopy for the detection of human ocular infections (23).
- A prospective, masked clinical trial of a 10-minute in-office immunoassay for detecting adenovirus conjunctivitis showed a
sensitivty of 89% and specificity of 94% compared to PCR, whereas viral cell culture showed a sensitivity of 91% and specificity
of 100% (24).
- According to a cost-effectiveness analysis, the majority of costs associated with acute conjunctivitis are related to unnecessary
antibiotic use and follow-up office visits. Broad implementation of a rapid, sensitive, and specific point-of-care diagnostic
device would result in more than $430 million in U.S. health care savings. Additionally, approximately 1 million unnecessary
antibiotic prescriptions are written annually (25).
|
|
Comments:
- Infectious conjunctivitis has been shown to be 42% to 80% bacterial, 3% chlamydial, and 13% to 60% viral. Adenovirus is the
most common cause of conjunctivitis and represents about 80% to 90% of all viral conjunctivitis (2; 9; 16; 18; 24; 26).
- Studies suggest that it is often difficult to differentiate viral from bacterial or allergic disease by the clinical exam.
Clinical accuracy of about 40% to 70% compared to laboratory confirmation has been shown (6; 7; 9; 17; 18).
- HSV can present without an associated skin rash in an identical fashion as adenovirus 4% to 5% of the time (5).
|
| FAQs |
|
|
|
Robert Sambursky, MD, editorial consultant, Chief Medical Officer for Rapid Pathogen Screening, Inc.;served as consultant for Rapid Pathogen Screening, Inc.;received
an honoraria for Rapid Pathogen Screening, Inc.;serves as consultant for Rapid Pathogen Screening, Inc; owns stock options
in Rapid Pathogen Screening, Inc.;served as board member or director for Rapid Pathogen Screening, Inc.;received grants and
has grants pending from Rapid Pathogen Screening, Inc.;and has received patents and has patents pending for Rapid Pathogen
Screening, Inc. Stephen Orlin, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for
continuing medical education grand rounds and lectures given.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|